Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) EPS (Weighted Average and Diluted) (2021 - 2025)

Q32 Bio (QTTB) has 5 years of EPS (Weighted Average and Diluted) data on record, last reported at $4.7 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 78.71% year-over-year to $4.7; the TTM value through Dec 2025 reached $2.42, up 136.78%, while the annual FY2025 figure was $2.42, 136.78% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $4.7 in Q4 2025 per QTTB's latest filing, up from -$0.6 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $4.7 in Q4 2025 and bottomed at -$152.28 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$11.77, with a median of -$0.6 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 8050.0% in 2022, then crashed 25280.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.59 in 2021, then dropped by 1.69% to -$0.6 in 2022, then plummeted by 25280.0% to -$152.28 in 2023, then surged by 101.73% to $2.63 in 2024, then soared by 78.71% to $4.7 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $4.7 in Q4 2025, -$0.6 in Q3 2025, and -$0.78 in Q2 2025.